These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 29492662)

  • 1. Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities.
    Picconi B; De Leonibus E; Calabresi P
    J Neural Transm (Vienna); 2018 Aug; 125(8):1263-1271. PubMed ID: 29492662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia.
    Cerovic M; Bagetta V; Pendolino V; Ghiglieri V; Fasano S; Morella I; Hardingham N; Heuer A; Papale A; Marchisella F; Giampà C; Calabresi P; Picconi B; Brambilla R
    Biol Psychiatry; 2015 Jan; 77(2):106-15. PubMed ID: 24844602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms.
    Ghiglieri V; Mineo D; Vannelli A; Cacace F; Mancini M; Pendolino V; Napolitano F; di Maio A; Mellone M; Stanic J; Tronci E; Fidalgo C; Stancampiano R; Carta M; Calabresi P; Gardoni F; Usiello A; Picconi B
    Neurobiol Dis; 2016 Feb; 86():140-53. PubMed ID: 26639853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
    Suárez LM; Solís O; Caramés JM; Taravini IR; Solís JM; Murer MG; Moratalla R
    Biol Psychiatry; 2014 May; 75(9):711-22. PubMed ID: 23769604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zooming in on the small: the plasticity of striatal dendritic spines in L-DOPA-induced dyskinesia.
    Fieblinger T; Cenci MA
    Mov Disord; 2015 Apr; 30(4):484-93. PubMed ID: 25759263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment.
    Belujon P; Lodge DJ; Grace AA
    Mov Disord; 2010 Aug; 25(11):1568-76. PubMed ID: 20623773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic plasticity may underlie l-DOPA induced dyskinesia.
    Borgkvist A; Lieberman OJ; Sulzer D
    Curr Opin Neurobiol; 2018 Feb; 48():71-78. PubMed ID: 29125979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia.
    Picconi B; Centonze D; Håkansson K; Bernardi G; Greengard P; Fisone G; Cenci MA; Calabresi P
    Nat Neurosci; 2003 May; 6(5):501-6. PubMed ID: 12665799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic dysfunction in Parkinson's disease.
    Bagetta V; Ghiglieri V; Sgobio C; Calabresi P; Picconi B
    Biochem Soc Trans; 2010 Apr; 38(2):493-7. PubMed ID: 20298209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia.
    Prescott IA; Liu LD; Dostrovsky JO; Hodaie M; Lozano AM; Hutchison WD
    Neurobiol Dis; 2014 Nov; 71():24-33. PubMed ID: 25116960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.
    Errico F; Bonito-Oliva A; Bagetta V; Vitucci D; Romano R; Zianni E; Napolitano F; Marinucci S; Di Luca M; Calabresi P; Fisone G; Carta M; Picconi B; Gardoni F; Usiello A
    Exp Neurol; 2011 Dec; 232(2):240-50. PubMed ID: 21946266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?
    Calabresi P; Ghiglieri V; Mazzocchetti P; Corbelli I; Picconi B
    Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1672):. PubMed ID: 26009763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior.
    de Iure A; Napolitano F; Beck G; Quiroga Varela A; Durante V; Sciaccaluga M; Mazzocchetti P; Megaro A; Tantucci M; Cardinale A; Punzo D; Mancini A; Costa C; Ghiglieri V; Tozzi A; Picconi B; Papa SM; Usiello A; Calabresi P
    Mov Disord; 2019 Jun; 34(6):832-844. PubMed ID: 30759320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia.
    Ueno T; Yamada J; Nishijima H; Arai A; Migita K; Baba M; Ueno S; Tomiyama M
    Neurobiol Dis; 2014 Apr; 64():142-9. PubMed ID: 24398173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maladaptive Synaptic Plasticity in L-DOPA-Induced Dyskinesia.
    Wang Q; Zhang W
    Front Neural Circuits; 2016; 10():105. PubMed ID: 28066191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation.
    Picconi B; Paillé V; Ghiglieri V; Bagetta V; Barone I; Lindgren HS; Bernardi G; Angela Cenci M; Calabresi P
    Neurobiol Dis; 2008 Feb; 29(2):327-35. PubMed ID: 17997101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal plasticity in Parkinson's disease and L-dopa induced dyskinesia.
    Iravani MM; McCreary AC; Jenner P
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S123-5. PubMed ID: 22166408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa treatment and dendritic spine pathology.
    Nishijima H; Ueno T; Funamizu Y; Ueno S; Tomiyama M
    Mov Disord; 2018 Jul; 33(6):877-888. PubMed ID: 28880414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal synaptic plasticity: implications for motor learning and Parkinson's disease.
    Pisani A; Centonze D; Bernardi G; Calabresi P
    Mov Disord; 2005 Apr; 20(4):395-402. PubMed ID: 15719415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective activation of striatal indirect pathway suppresses levodopa induced-dyskinesias.
    Castela I; Casado-Polanco R; Rubio YV; da Silva JA; Marquez R; Pro B; Moratalla R; Redgrave P; Costa RM; Obeso J; Hernandez LF
    Neurobiol Dis; 2023 Jan; 176():105930. PubMed ID: 36414182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.